Proteogenomic analysis of the CALGB 40601 (Alliance) HER2+ breast cancer neoadjuvant trial reveals resistance biomarkersEric J. Jaehnig, Meenakshi Anurag, Haoquan Zhao et al.|Cell Reports Medicine|2025Cited by 3
Supplementary Table S1 from FGFR1-Activated Translation of WNT Pathway Components with Structured 5′ UTRs Is Vulnerable to Inhibition of EIF4A-Dependent Translation InitiationTuan M. Nguyen, Jeffrey M. Rosen, Richard E. Lloyd et al.|Unknown|2023Cited by 0
Supplementary Table S1 from FGFR1-Activated Translation of WNT Pathway Components with Structured 5′ UTRs Is Vulnerable to Inhibition of EIF4A-Dependent Translation InitiationTuan M. Nguyen, Jeffrey M. Rosen, Anna Malovannaya et al.|Unknown|2023Cited by 0
Supplementary Figure S4 from FGFR1-Activated Translation of WNT Pathway Components with Structured 5′ UTRs Is Vulnerable to Inhibition of EIF4A-Dependent Translation InitiationTuan M. Nguyen, Jeffrey M. Rosen, Anna Malovannaya et al.|Unknown|2023Cited by 0